Skip to Content

Positron Corp POSC

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Positron Corp is a US-based nuclear medicine healthcare company. It operates in the field of cardiac Positron Emission Tomography (PET) imaging - the gold standard diagnostic test in nuclear cardiology. The cardiac PET is the superior method in diagnostic nuclear imaging for the detection of coronary artery disease, a leading cause of death in the United States. It offers Positron Emission Tomography imaging system, clinical and support services, radiopharmaceuticals, and radioisotope processing and production. Based on product lines, manufacturing processes, marketing and management of businesses, it operates through medical equipment and radiopharmaceuticals segments. The company derives revenues from the sale of medical equipment products, maintenance contracts, and service revenues.

1777 Maryland Avenue
Niagara Falls, NY, 14305
T +1 317 576-0183
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Sep 30, 2015
Fiscal Year End Dec 31, 2020
Stock Type Distressed
Employees 19